Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Vitiligo is a skin condition causing white patches, likely due to an autoimmune issue.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.